Choline Alfoscerate Has Modest Benefits on Cognition in T2D ...Middle East

Medscape - News
Choline Alfoscerate Has Modest Benefits on Cognition in T2D
Daily treatment with 1200 mg of choline alfoscerate showed marginal improvement in cognitive function in patients with T2D and mild cognitive impairment, according to a randomized trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Choline Alfoscerate Has Modest Benefits on Cognition in T2D )

Also on site :



Latest News